CC - The Chemours Company

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
5,637,000
5,526,000
6,638,000
6,183,000
5,400,000
Cost of Revenue
4,324,000
4,463,000
4,667,000
4,429,000
4,290,000
Gross Profit
1,313,000
1,063,000
1,971,000
1,754,000
1,110,000
Operating Expenses
Research Development
82,000
80,000
82,000
80,000
80,000
Selling General and Administrative
614,000
548,000
657,000
602,000
934,000
Total Operating Expenses
696,000
651,000
739,000
682,000
1,014,000
Operating Income or Loss
617,000
412,000
1,232,000
1,072,000
96,000
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
98,000
-328,000
118,000
55,000
106,000
Income Before Tax
512,000
-124,000
1,155,000
912,000
-11,000
Income Tax Expense
105,000
-72,000
159,000
165,000
-18,000
Income from Continuing Operations
407,000
-52,000
996,000
747,000
7,000
Net Income
407,000
-52,000
995,000
746,000
7,000
Net Income available to common shareholders
407,000
-52,000
995,000
746,000
7,000
Reported EPS
Basic
-
-0.32
5.62
4.04
0.04
Diluted
-
-0.32
5.45
3.91
0.04
Weighted average shares outstanding
Basic
-
164,817
176,969
184,844
181,621
Diluted
-
164,817
182,572
190,984
183,417
EBITDA
-
723,000
1,516,000
1,345,000
380,000